NDV01 KIT

· Relmada Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for NDV01 KIT, covering 2025-06-13 to 2025-06-13. Get the full timeline:

Most recent: Clinical Trial Update: Open Label Study to Evaluate the Safety and Efficacy of NDV01 KIT in High Grade NMIBC [Phase 2]